DELCATH SYSTEMS (DCTH) Q3 2025 TL;DR (9 Months Ended Sept. 30, 2025)
Financial Turnaround and Liquidity: DCTH achieved a dramatic financial reversal, reporting a $4.6M Net Income for the nine months ended September 30, 2025, compared to a $23.0M loss in 2024. Revenue surged nearly threefold to $64.5M ($59.8M from HEPZATO KIT). The company shifted from consuming $17.7M in operating cash flow in 2024 to providing $14.3M in operating cash flow in 2025. Total liquidity is strong, with $88.9M in cash and short-term investments, supporting operations for at least 12 m
...